Delivery Order SPE2DB22D3016-SPE2DB25FBGH4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,340.37 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded order issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,018.76 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on October 17, 2025, with completion targeted for October 20, 2025. This competitively awarded, non-set-aside order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,354.16 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on November 5, 2025, with completion targeted for November 6, 2025. This firm fixed-price delivery order represents a non-competitive award and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,990.49 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on July 31, 2025, with completion scheduled for August 1, 2025. This firm fixed-price, non-competitive delivery order represents a small-value pharmaceutical procurement executed under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $46,456.89 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price, competitively awarded delivery order was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,812.48 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on October 21, 2025, with an ultimate completion date of October 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $2,448.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). The contract is scheduled for completion by September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,416.57 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on November 4, 2025, with an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,694.15 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Mounjaro 15 mg/0.5 ml pens, with an ultimate completion date of October 23, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $2,796.54 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGH4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $48,915.64 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime contract vehicle that runs through December 2026 and serves as the company's comprehensive global pharmaceutical support mechanism for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor specializing in a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Mounjaro, a diabetes management medication, exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles that enable rapid pharmaceutical supply to meet military and veteran healthcare needs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.9k | 8/26/25 |